Choice of hypomethylating agent for newly diagnosed TP53-mutant acute myeloid Leukemia: a COMMAND registry study. uri icon

authors

  • Badar, Talha
  • Coltoff, Alexander
  • Goldberg, Aaron D
  • Bewersdorf, Jan P
  • Zabel, Kenneth M
  • Foucar, Charles
  • Abaza, Yasmin
  • Murthy, Guru S
  • Palmisiano, Neil
  • DuVall, Adam S
  • Kota, Vamsi
  • Foran, James
  • Patel, Shyam A
  • Zeidan, Amer M
  • Murthy, Hemant
  • Kharfan-Dabaja, Mohamed
  • Atallah, Ehab
  • Litzow, Mark R
  • Jamy, Omer
  • Lin, Chenyu
  • Patel, Anand
  • Wang, Yu-Hung
  • Manish Kumar, MD
  • Shallis, Rory M
  • Diebold, Kendall

publication date

  • August 31, 2026